JLE

European Journal of Dermatology

MENU

sQuiz editorial: Latent tuberculosis infection: Update of diagnosis before the introduction of biologic drugs Volume 25, issue 6, November-December 2015

Authors
Dermatology Unit, Complejo Hospitalario Universitario Granada, Spain

Screening of latent tuberculosis infection (LTI) in patients who are going to undergo treatment with biologic drugs (TNF blockers and anti-IL-2/23) to manage moderate-to-severe psoriasis has become an important issue in countries such as Spain, with one of the highest tuberculosis incident rates of Western Europe (13 new cases per 100,000 persons-year, World Health Organization reports) [1]. Interferon-γ Release Assay (IGRA) has recently been introduced as a relevant diagnosis method which could [...]